Agilent Technologies (NYSE:A) Issues FY 2026 Earnings Guidance

Agilent Technologies (NYSE:A) updated its FY 2026 earnings guidance on Wednesday. The company provided earnings per share guidance of 5.900-6.040 for the period, compared to the consensus earnings per share estimate of 5.930. The company issued revenue guidance of $7.3 billion-$7.5 billion, compared to the consensus revenue estimate of $7.3 billion. Agilent Technologies also updated its Q2 2026 guidance to 1.390-1.420 EPS.

Analyst Ratings Changes

Several brokerages have recently weighed in on A. Barclays raised shares of Agilent Technologies from an “equal weight” rating to an “overweight” rating and set a $165.00 target price on the stock in a research note on Monday, December 15th. Bank of America lifted their price objective on shares of Agilent Technologies from $150.00 to $165.00 and gave the stock a “neutral” rating in a research note on Tuesday, November 25th. JPMorgan Chase & Co. lifted their price objective on Agilent Technologies from $165.00 to $180.00 and gave the company an “overweight” rating in a research note on Tuesday, November 25th. UBS Group raised their price target on shares of Agilent Technologies from $170.00 to $180.00 and gave the company a “buy” rating in a research report on Tuesday, November 25th. Finally, Wells Fargo & Company lifted their target price on shares of Agilent Technologies from $150.00 to $175.00 and gave the company an “overweight” rating in a research report on Tuesday, November 25th. Two research analysts have rated the stock with a Strong Buy rating, eleven have issued a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat, Agilent Technologies currently has a consensus rating of “Moderate Buy” and a consensus target price of $164.50.

Agilent Technologies Trading Up 0.4%

A traded up $0.45 during trading hours on Wednesday, reaching $124.85. The company’s stock had a trading volume of 2,457,707 shares, compared to its average volume of 2,096,712. Agilent Technologies has a fifty-two week low of $96.43 and a fifty-two week high of $160.27. The business’s 50-day moving average is $135.55 and its 200-day moving average is $136.05. The stock has a market cap of $35.31 billion, a PE ratio of 27.32, a P/E/G ratio of 3.61 and a beta of 1.30. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.96 and a quick ratio of 1.52.

Agilent Technologies (NYSE:A) last announced its earnings results on Wednesday, February 25th. The medical research company reported $1.36 earnings per share for the quarter, missing the consensus estimate of $1.37 by ($0.01). The company had revenue of $1.80 billion for the quarter, compared to analysts’ expectations of $1.81 billion. Agilent Technologies had a return on equity of 25.20% and a net margin of 18.75%.Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. As a group, equities research analysts predict that Agilent Technologies will post 5.58 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, April 22nd. Investors of record on Tuesday, March 31st will be paid a dividend of $0.255 per share. The ex-dividend date is Tuesday, March 31st. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.8%. Agilent Technologies’s payout ratio is presently 22.32%.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the stock. Fiduciary Trust Co lifted its holdings in shares of Agilent Technologies by 1.6% during the 3rd quarter. Fiduciary Trust Co now owns 4,931 shares of the medical research company’s stock valued at $633,000 after acquiring an additional 77 shares in the last quarter. IHT Wealth Management LLC increased its stake in Agilent Technologies by 4.9% during the 4th quarter. IHT Wealth Management LLC now owns 2,041 shares of the medical research company’s stock worth $278,000 after buying an additional 96 shares during the period. UMB Bank n.a. boosted its position in Agilent Technologies by 3.0% in the 4th quarter. UMB Bank n.a. now owns 4,500 shares of the medical research company’s stock valued at $612,000 after buying an additional 131 shares during the last quarter. Zions Bancorporation National Association UT grew its stake in shares of Agilent Technologies by 17.2% during the fourth quarter. Zions Bancorporation National Association UT now owns 990 shares of the medical research company’s stock valued at $135,000 after acquiring an additional 145 shares in the last quarter. Finally, Modern Wealth Management LLC grew its stake in shares of Agilent Technologies by 5.7% during the second quarter. Modern Wealth Management LLC now owns 2,889 shares of the medical research company’s stock valued at $341,000 after acquiring an additional 157 shares in the last quarter.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.